NCT04159532View on ClinicalTrials.gov

Comparative Study of Three Different Formulations of Omega-3 (EPA+DHA)

PHASE4CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

December 18, 2019

Primary Completion Date

February 25, 2021

Study Completion Date

February 25, 2021

Conditions
Healthy Adults
Interventions
DIETARY_SUPPLEMENT

MAG-EPA/MAG-DHA

monoglyceride of eicosapentaenoic acid and docosahexaenoic acid in proportion of 460:200

DIETARY_SUPPLEMENT

TG-EPA/TG-DHA

Triglyceride of eicosapentaenoic acid and docosahexaenoic acid in proportion of 460:200

DIETARY_SUPPLEMENT

EE-EPA/EE-DHA

Ethyl ester of eicosapentaenoic acid and docosahexaenoic acid in proportion of 460:200

Trial Locations (1)

G0K 1P0

SCF pharma, Rimouski

All Listed Sponsors
lead

SCF Pharma

INDUSTRY

NCT04159532 - Comparative Study of Three Different Formulations of Omega-3 (EPA+DHA) | Biotech Hunter | Biotech Hunter